Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Michael Randall, MD

Photo of Michael Randall, MD
Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address654 Minnesota Street
San Francisco CA 94107
PronounsHe/Him/His
ORCID ORCID Icon0000-0002-8687-1514 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Dartmouth College, Hanover, NHBA06/2012
    University of Pennsylvania, Philadelphia, PAMD05/2019
    Johns Hopkins Hospital, Baltimore, MD06/2022Internal Medicine Residency

    Collapse Overview 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). J Natl Compr Canc Netw. 2026 Mar 31; 24(3.5). Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. PMID: 41921576.
      View in: PubMed   Mentions:    Fields:    
    2. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). J Natl Compr Canc Netw. 2026 Mar 31; 24(3.5). Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. PMID: 41991041.
      View in: PubMed   Mentions:    Fields:    
    3. Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone Marrow Transplant. 2024 Aug; 59(8):1178-1180. Sinanidis I, Hochman MJ, Tsai HL, Randall MP, Bonilla B, Varadhan R, Ambinder AJ, Jones RJ, DeZern AE, Karantanos T. PMID: 38714755.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. J Natl Cancer Inst. 2024 01 10; 116(1):138-148. Randall MP, Egolf LE, Vaksman Z, Samanta M, Tsang M, Groff D, Evans JP, Rokita JL, Layeghifard M, Shlien A, Maris JM, Diskin SJ, Bosse KR. PMID: 37688570; PMCID: PMC10777668.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    5. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. J Natl Cancer Inst. 2024 01 10; 116(1):149-159. Kim J, Vaksman Z, Egolf LE, Kaufman R, Evans JP, Conkrite KL, Danesh A, Lopez G, Randall MP, Dent MH, Farra LM, Menghani NL, Dymek M, Desai H, Hausler R, Hicks B, Guidry Auvil M, Gerhard DS, Hakonarson H, Maxwell KN, Cole KA, Pugh TJ, Bosse KR, Khan J, Wei JS, Maris JM, Stewart DR, Diskin SJ. PMID: 37688579; PMCID: PMC10777667.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    6. Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy. Cancers (Basel). 2023 Sep 11; 15(18). Randall MP, Spinner MA. PMID: 37760478; PMCID: PMC10526852.
      View in: PubMed   Mentions: 9  
    7. The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances. Cancer J. 2023 May-Jun 01; 29(3):152-159. Randall MP, DeZern AE. PMID: 37195771.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Tafasitamab at the blood-brain barrier. Br J Haematol. 2023 04; 201(1):154-157. Rauschecker AM, Mo SS, Randall M, Shen-Sampas J, Rubenstein JL. PMID: 36691708.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Genetic susceptibility to neuroblastoma: current knowledge and future directions. Cell Tissue Res. 2018 05; 372(2):287-307. Ritenour LE, Randall MP, Bosse KR, Diskin SJ. PMID: 29589100; PMCID: PMC6893873.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    10. Axin phosphorylation in both Wnt-off and Wnt-on states requires the tumor suppressor APC. PLoS Genet. 2018 02; 14(2):e1007178. Tacchelly-Benites O, Wang Z, Yang E, Benchabane H, Tian A, Randall MP, Ahmed Y. PMID: 29408853; PMCID: PMC5800574.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    11. A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma. J Gastrointest Oncol. 2018 Feb; 9(1):1-10. Windon AL, Loaiza-Bonilla A, Jensen CE, Randall M, Morrissette JJD, Shroff SG. PMID: 29564165; PMCID: PMC5848049.
      View in: PubMed   Mentions: 37  
    12. Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma. Cancer Cell. 2017 09 11; 32(3):295-309.e12. Bosse KR, Raman P, Zhu Z, Lane M, Martinez D, Heitzeneder S, Rathi KS, Kendsersky NM, Randall M, Donovan L, Morrissy S, Sussman RT, Zhelev DV, Feng Y, Wang Y, Hwang J, Lopez G, Harenza JL, Wei JS, Pawel B, Bhatti T, Santi M, Ganguly A, Khan J, Marra MA, Taylor MD, Dimitrov DS, Mackall CL, Maris JM. PMID: 28898695; PMCID: PMC5600520.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansAnimalsCells
    13. Wnt pathway activation by ADP-ribosylation. Nat Commun. 2016 May 03; 7:11430. Yang E, Tacchelly-Benites O, Wang Z, Randall MP, Tian A, Benchabane H, Freemantle S, Pikielny C, Tolwinski NS, Lee E, Ahmed Y. PMID: 27138857; PMCID: PMC4857404.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    14. Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes. MAbs. 2016 May-Jun; 8(4):799-810. Feng Y, Wang Y, Zhu Z, Li W, Sussman RT, Randall M, Bosse KR, Maris JM, Dimitrov DS. PMID: 26910291; PMCID: PMC4966860.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    Michael's Networks
    Concepts (82)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-22-g09c84f92 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.